214 related articles for article (PubMed ID: 18673359)
21. Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring.
Elidemir O; Kancherla BS; Schecter MG; McKenzie ED; Morales DL; Heinle JS; Mallory GB
Pediatr Transplant; 2009 Aug; 13(5):606-10. PubMed ID: 19017289
[TBL] [Abstract][Full Text] [Related]
22. Post-Transplant Lymphoproliferative Disorder (PTLD) Manifesting in the Oral Cavity of a 13-Year-Old Liver Transplant Recipient (LTx).
Krasuska-Sławińska E; Minko-Chojnowska I; Pawłowska J; Dembowska-Bagińska B; Pronicki M; Olczak-Kowalczyk D
Ann Transplant; 2015 Aug; 20():478-82. PubMed ID: 26285106
[TBL] [Abstract][Full Text] [Related]
23. Rapid response to rituximab in a pediatric liver transplant recipient with post-transplant lymphoproliferative disease and maintenance with sirolimus monotherapy.
Al-Akash SI; Al Makadma AS; Al Omari MG
Pediatr Transplant; 2005 Apr; 9(2):249-53. PubMed ID: 15787802
[TBL] [Abstract][Full Text] [Related]
24. Post-transplantation lymphoproliferative disorders localizing to the gastrointestinal tract after liver transplantation: report of five pediatric cases.
Lai YC; Ni YH; Jou ST; Ho MC; Wu JF; Chen HL; Hu RH; Jeng YM; Chang MH; Lee PH
Pediatr Transplant; 2006 May; 10(3):390-4. PubMed ID: 16677368
[TBL] [Abstract][Full Text] [Related]
25. [Clinico-pathological analysis of 6 cases of post-transplant lymphoproliferative disorders].
Wang ZM; Zheng SS; Ding W; Wang LJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):514-8. PubMed ID: 18078125
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-associated lymphoproliferative disease in oral cavity in a renal transplant recipient: a case report.
Johnson J; Kerecuk L; Harrison M; Taylor JO; Odell E
Pediatr Transplant; 2007 May; 11(3):340-4. PubMed ID: 17430495
[TBL] [Abstract][Full Text] [Related]
27. Nasopharyngeal T-cell monomorphic posttransplant lymphoproliferative disorders and combined IgA nephropathy and membranous glomerulonephritis in a patient with renal transplantation: a case report with literature review.
Kfoury HK; Alghonaim M; AlSuwaida AK; Zaidi SN; Arafah M
Transplant Proc; 2010 Dec; 42(10):4653-7. PubMed ID: 21168754
[TBL] [Abstract][Full Text] [Related]
28. Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties.
Ziarkiewicz-Wróblewska B; Górnicka B; Suleiman W; Ołdakowska-Jedynak U; Wróblewski T; Bogdańska M; Ziółkowski J; Nowacka-Cieciura E; Foroncewicz B; Pileri SA; Durlik M; Paczek L; Krawczyk M; Wasiutyński A
Transplant Proc; 2006; 38(1):168-72. PubMed ID: 16504694
[TBL] [Abstract][Full Text] [Related]
29. Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome.
Fernández MC; Bes D; De Dávila M; López S; Cambaceres C; Dip M; Imventarza O
Pediatr Transplant; 2009 May; 13(3):307-10. PubMed ID: 18346039
[TBL] [Abstract][Full Text] [Related]
30. What delay should there be between primary infectious mononucleosis and renal transplantation?
Kerecuk L; Amlot P; Riad H; Webb NJ
Pediatr Transplant; 2006 Dec; 10(8):970-3. PubMed ID: 17096769
[TBL] [Abstract][Full Text] [Related]
31. Posttransplant lymphoproliferative disorder in the wall of a lymphocele: a case report.
Basic-Jukic N; Kes P; Coric M; Kastelan Z; Pasini J; Bubic-Filipi L
Transplant Proc; 2009 Jun; 41(5):1966-8. PubMed ID: 19545769
[TBL] [Abstract][Full Text] [Related]
32. Post-transplant lymphoproliferative disorder: no relationship to recombinant human growth hormone use in Australian and New Zealand pediatric kidney transplant recipients.
Longmore DK; Conwell LS; Burke JR; McDonald SP; McTaggart SJ
Pediatr Transplant; 2013 Dec; 17(8):731-6. PubMed ID: 24164826
[TBL] [Abstract][Full Text] [Related]
33. Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation.
Dharnidharka VR; Stevens G
Pediatr Transplant; 2005 Oct; 9(5):622-6. PubMed ID: 16176420
[TBL] [Abstract][Full Text] [Related]
34. [Post transplant lymphoprolipherative disorder (PTLD) in patients after kidney transplantation--clinical manifestation, treatment and prognosis].
Pałka K; Ignacak E; Sułowicz W
Przegl Lek; 2012; 69(9):675-9. PubMed ID: 23401988
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis and Epstein-Barr virus in the tonsils of transplant recipients and healthy controls.
Mowry SE; Strocker AM; Chan J; Takehana C; Kalantar N; Bhuta S; Shapiro NL
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):936-9. PubMed ID: 18794437
[TBL] [Abstract][Full Text] [Related]
36. A case of laryngeal posttransplantation lymphoproliferative disease.
Lee HH; Lee DS; Park JH; Lee KW; Kim SJ; Joh JW; Seo JM; Kwon GY; Choe YH; Lee SK
Transplant Proc; 2004 Oct; 36(8):2305-6. PubMed ID: 15561230
[TBL] [Abstract][Full Text] [Related]
37. Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab.
Svoboda J; Kotloff R; Tsai DE
Transpl Int; 2006 Apr; 19(4):259-69. PubMed ID: 16573540
[TBL] [Abstract][Full Text] [Related]
38. Development of lymphoproliferative disease after liver transplantation.
Marqués E; Jiménez C; Manrique A; Vallejo GH; Clemares M; Ortega P; Moreno E
Transplant Proc; 2008 Nov; 40(9):2988-9. PubMed ID: 19010169
[TBL] [Abstract][Full Text] [Related]
39. Successful laser ablation of diffuse laryngeal swelling in posttransplant lymphoproliferative disorder: the Japanese first case.
Nishimura K; Omori K; Haga H; Fujimoto Y; Ito J
Int J Pediatr Otorhinolaryngol; 2005 Jun; 69(6):869-73. PubMed ID: 15885345
[TBL] [Abstract][Full Text] [Related]
40. Tonsil enlargement after liver transplantation in adults--reason enough for tonsillectomy? Two cases of tonsillar posttransplantation lymphoproliferative disease.
Mucha K; Foroncewicz B; Niemczyk K; Ziarkiewicz-Wróblewska B; Stanisławek-Sut O; Zieniewicz K; Krawczyk M; Paczek L
Liver Transpl; 2007 Jun; 13(6):918-23. PubMed ID: 17539016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
